New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim

A new research team at XSeed Labs – a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models to understand wound healing and fibrosis.

RIDGEFIELD, CT / ACCESSWIRE / May 16, 2024 / XSeed Labs – a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. This research team’s main objective is to develop complex, physiologically relevant disease models that deepen our understanding of dysfunctional wound healing and fibrosis. The end goal is to study fibrosis, drug delivery strategies, and drug safety in parallel, in an effort to bridge the gap between research and development to improve patient outcomes accurately and efficiently.

The new research team is led by Dr. Lorenzo Talà, Group Leader at XSeed Labs. "Due to insufficient understanding of the mechanisms driving their pathology, therapies to treat fibrotic diseases are limited. The aim of our research group is to develop physiologically relevant in vitro and in silico fibrosis models. By combining both approaches, we will interrogate disease mechanisms, identify drug delivery pathways, and assess drug safety in order to facilitate drug development toward resolving fibrotic tissues."

Christian Tidona, Founder and Managing Director of the BioMed X Institute: "We are pleased that we could successfully translate the innovation model we established in Heidelberg and New Haven to work inside a major pharma research and development campus. We have a long history of successful collaboration with Boehringer Ingelheim at our Heidelberg institute, and we are proud to extend this collaboration to their U.S. headquarters in Ridgefield, Connecticut."

"We are committed to accelerating innovation across fibrotic diseases. This partnership allows us to harness top talent across the biomedical industry and leverage our leading research and development site in the U.S. to discover insights that could help transform the way we treat these diseases," said Carine Boustany, PhD, U.S. Research Site Head and Global Head of Immunology and Respiratory Diseases Research, Boehringer Ingelheim. "In parallel, we will harness these innovative disease model systems to assess the safety of novel anti-fibrotic concepts, and identify better ways to deliver our molecules," said Xiaorong He, PhD, U.S. Development Site Head and Global Head of Development Sciences, Boehringer Ingelheim.

"We are excited to start our first XSeed Labs team at Boehringer Ingelheim in Ridgefield. It is the beginning of a unique innovation model that promotes scientific exchange between major players in biomedical research," says Mark Johnston, CEO of BioMed X USA.

About BioMed X and XSeed Labs

BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds — academia and industry — and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

BioMed X started working with Boehringer Ingelheim in 2015 with a series of joint research projects hosted by the BioMed X Institute in Heidelberg, Germany. The new collaboration model – called XSeed Labs – entails an open innovation incubator embedded in the Boehringer Ingelheim Ridgefield campus in Connecticut, USA.

Contact Information

Flavia-Bianca Cristian
Recruiting & Communications Manager
fbc@bio.mx
+49 6221 426 11 706

Swathi Lingam
Scientific Communication & Editorial Associate
lingam@bio.mx
+49 6221 426 11 27

Related Images

SOURCE: BioMed X Institute & XSeed Labs

.

View the original press release on newswire.com.

DEXIS Innovation Continues With New DEXIS Ti2 Sensor as Successor to the DEXIS Titanium Sensor, the #1 Selling Intraoral Sensor in the United States

QUAKERTOWN, PA / ACCESSWIRE / May 16, 2024 / Today, DEXIS launches the latest innovation in its digital ecosystem with an all-new dental intraoral sensor, the DEXIS™ Ti2 Sensor. The DEXIS digital ecosystem is a comprehensive, AI-powered platform for dental imaging, designed to connect and streamline digital workflows for enhanced productivity.

DEXIS Ti2 Sensor
DEXIS Ti2 Sensor
DEXIS Ti2 Sensor

The Ti2 sensor builds on the success of its predecessor, the DEXIS™ Titanium Sensor, the #1 digital intraoral sensor in the United States.* In 2023, DEXIS sensors processed over 167 million images, making it a top choice for intraoral sensors and scanners, as well as x-ray and CBCT technology worldwide.

Bringing several new features to the DEXIS 2D imaging portfolio, the Ti2 sensor includes:

  • A housing design that’s twice as durable as previous generations
  • A proactive servicing module
  • Access to 2D AI Dental Findings that automatically detect up to six types of dental findings on 2D radiographs

With DEXIS, 2D AI Dental Findings are integrated into both DTX Studio™ Clinic and DEXIS Imaging Suite software-not a separate third-party application. 2D AI Dental Findings automatically identifies periapical radiolucency, bone loss, calculus, caries, discrepancy at margin of existing restoration, and root canal filling deficiency.

"For patients with periodontal disease, we have identified sub-gingival calculus and monitored their bone levels. Caries detection and diagnosis is clear and precise with the contrast available with these images," said Dr. Moe Katz of Katz & Pfeffer Dental Studio.

The Ti2 sensor housing is twice as durable and two times as drop-resistant as the Titanium Sensor. The new posterior holder and WiseAngle™ cable design reduce stress on the sensor/cable connection, further strengthening the Ti2 sensor.

DEXIS also focuses on maximizing the productivity of the dental practice with the newly launched DEXIS Connect Pro. The solution proactively monitors the health of the DEXIS family of sensors through IoT technology and automatically arranges support or equipment replacements if performance issues are ever detected.

"DEXIS Connect Pro provides the kind of customer experience I’ve come to expect from DEXIS," says Amber Metro-Sanchez, dental hygienist at Omni Dental. "The knowledge that my sensor communicates with DEXIS support and that they’re ready to help me if I ever need it gives me peace of mind. They’ve always been so responsive and helpful, DEXIS Connect Pro demonstrates the kind of attention to customer care and continuous innovation I’ve grown accustomed to with DEXIS."

Through the use of CleanCapture™ technology, the Ti2 sensor captures high-resolution images by reducing noise and enhancing anatomical detail. The technology allows the sensor to be flexible and ready to adapt to varying exposure levels, generator usage, or positioning techniques to capture clear, accurate images reliably – even in challenging circumstances.

Equipped with its PerfectSize™ design, the Ti2 sensor is engineered to fit every patient comfortably, making it a convenient, one-size-fits-all solution for busy practices.

Experience the new DEXIS Ti2 Sensor at booth 1665 at CDA South on May 16-18, 2024.

*DEXIS Titanium Sensor- December 2023 SDM US Market Share Data.

About DEXIS 

DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide patients with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances how the patient is diagnosed, accelerates the workflow, and delivers simple treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.

Contact Information:

Hayley Reed
Regional Marketing Director, DEXIS IOS
hayley.reed@envistaco.com
(714) 628-8533

SOURCE: DEXIS

.

View the original press release on newswire.com.

2024 Asian Taekwondo Championship sees record number of participants


The 2024 Asian Taekwondo Championship is gathering the highest number of participants in the tournament’s history, President of the Vietnam Taekwondo Federation Truong Ngoc De said at its May 16 opening ceremony held in the central city of Da Nang. The championship has attracted the participation of over 1,000 athletes, coaches, and officials from 45 countries, including many nations renowned for their Taekwondo movements such as the Republic of Korea, China, Iran, Uzbekistan, and Qatar.

Source: Vietnam News Agency

PM chairs meeting on fiscal, monetary policy management


Prime Minister Pham Minh Chinh chaired a meeting in Hanoi on May 16 with ministries and agencies to discuss the coordination of fiscal and monetary policies aimed at maintaining macroeconomic stability, controlling inflation and promoting growth.

Source: Vietnam News Agency

HCM City hails EU’s substantial contributions to local development


Ho Chi Minh City always appreciates and highly values the substantial contributions of EU countries to its development process, Vice Chairman of the municipal People’s Committee Duong Anh Duc remarked at the celebration of Europe Day 2024 held by the EU Delegation to Vietnam on May 16 evening.

Source: Vietnam News Agency

Conference seeks to deepen Vietnam-Russia bilateral cooperation


ASEAN countries, including Vietnam, are important priorities in Russia’s foreign policy in the Asia-Pacific region, Russian Ambassador to Vietnam G.S. Bezdetko said on May 15 at a conference jointly organised by the Vietnam Union of Friendship Organisations (VUFO), the Russian Embassy in Vietnam and Vietnam-Russia Friendship Association, aiming to share information about Russia and cooperation between the two countries.

Source: Vietnam News Agency